AbbVie received Food and Drug Administration approval of Emblaveo, an intravenous antibiotic, for treatment of adults with complicated intra-abdominal infections with limited or no treatment options.

NORTH CHICAGO, Ill. - The U.S. Food and Drug Administration (FDA) has approved EMBLAVEO™ (aztreonam and avibactam) for the ...

AbbVie said on Friday that the U.S. Food and Drug Administration approved its drug for complicated intra-abdominal infections ...

A new, comprehensive map of all the genes essential for blood infections in Plasmodium knowlesi (P. knowlesi), a parasite ...

New insights into what causes the painful and disruptive symptoms of urinary tract infections (UTIs) could offer hope for improved treatment. UTIs are one of the most prevalent bacterial infections ...

Swiss biotech BioVersys, which develops treatments for serious infections caused by drug resistant bacteria, has completed its initial public offering with an implied market valuation of 213 million ...

Antibiotics are indispensable for treating bacterial infections. But why are they sometimes ineffective, even when the bacteria are not resistant? In their latest study, researchers challenge the ...

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

Real-time imaging shows that bacterial resilience to antibiotics is not caused by a few ‘persisters’, but is a ...

Researchers have developed nanoflower-coated bandages with antibiotic and anti-inflammatory properties, capable of killing ...

Viral infections eventually lead to most cases ... from seasonal allergies or a bacterial infection requiring medical treatment. In recurrent acute sinusitis, you have at least four episodes ...

Preventing or treating infections could be a key means of warding off dementia, a new evidence review says. Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all ...